U.K. Approves Pfizer and BioNTech's COVID-19 Vaccine
The U.K. has become the first country to give emergency approval to the experimental COVID-19 vaccine from drugmakers Pfizer and BioNTech.
The United Kingdom is the first country to approve Pfizer and BioNTech’s COVID-19 vaccine. The reaction from Londoners-mixed.
"Personally, I would not want to take it because I think things are happening too quickly," said Tia Stephen, a London resident.
Jacqueline Roubians, a London resident, told the AP, "I mean, people are dying of COVID so you make that decision: do you want to die or do you want the vaccine?"
"I'm pretty confident to take it. You know, I think definitely myself and my family will be taking it because we need to get back to normal, I've had enough," Abi Babalola, another London resident, said.
The two-dose shots could start being distributed next week. In trials, this vaccine showed to be 95% effective.
"This vaccine, produced and developed by Pfizer BioNTech, meets rigorous high standards of safety, of effectiveness and of quality, the public's safety has always been at the forefront of our minds," Dr. June Raine, chief executive for the U.K.'s Medicines and Healthcare Products Regulatory Agency, said.
U.K. regulators say a "rolling review" of data had been used to make the most of time and was why approval happened so quickly, adding it "doesn't mean that any corners have been cut." The U.K. has secured enough doses for 20 million people but it’s unclear how many will arrive by the end of December. Priority is going to people 75 and older.
"The risk of dying from COVID-19 is very strongly associated with age. Age is by far the single most important factor in terms of risk from COVID-19," said professor Wei Shen Lim, chairman of the U.K. Joint Committee on Vaccination and Immunisation.
Moderna defends vax price hike, despite billions in taxpayer funding
The company is planning to raise the price of its COVID-19 vaccine from about $26 per dose up to $130 per dose.
What living with long COVID is really like
Scripps News talked to a dozen people with long-term COVID symptoms about their current experience and their hope for the future.
New data links COVID-19 pandemic's origins to raccoon dogs
The discovery does not prove that raccoon dogs or any other animals infected with COVID triggered the pandemic.
Are video games contributing to gambling problems?
Experts say the legalization of gambling, especially in mobile settings, is leading to a blurrier line between that and video games.
Ukrainian mom's visit to the US turned into a mission to help refugees
What started as visit to her son in Chicago is now a mission to help other Ukrainian refugees settle in the Windy City.
Woman sues artificial tears maker after loss of eyeball
Ezricare's artificial tears have been linked to a bacterial infection that is causing blindness, loss of eyes and even death.